Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
omega-3-carboxylic acids diacylglycerol o-acyltransferase 2 small molecule NA drugbank Hippocampus Proper[MeSHID:D006624]
Hypertriglyceridemia[MeSHID:D015228]
Disease[MeSHID:D004194]
Diet therapy[MeSHID:D004035]
Attention[MeSHID:D001288]
Alcohol consumption[MeSHID:D000428]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Neoplasm Metastasis[MeSHID:D009362]
Plasma[MeSHID:D010949]
Obesity[MeSHID:D009765]
Metabolic Syndrome X[MeSHID:D024821]		 NA approved,investigational antagonist
omega-3-carboxylic acids enoyl-coa hydratase, mitochondrial small molecule NA drugbank Hippocampus Proper[MeSHID:D006624]
Hypertriglyceridemia[MeSHID:D015228]
Disease[MeSHID:D004194]
Diet therapy[MeSHID:D004035]
Attention[MeSHID:D001288]
Alcohol consumption[MeSHID:D000428]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Neoplasm Metastasis[MeSHID:D009362]
Plasma[MeSHID:D010949]
Obesity[MeSHID:D009765]
Metabolic Syndrome X[MeSHID:D024821]		 NA approved,investigational potentiator
omega-3-carboxylic acids elongation of very long chain fatty acids protein 4 small molecule NA drugbank Hippocampus Proper[MeSHID:D006624]
Hypertriglyceridemia[MeSHID:D015228]
Disease[MeSHID:D004194]
Diet therapy[MeSHID:D004035]
Attention[MeSHID:D001288]
Alcohol consumption[MeSHID:D000428]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Neoplasm Metastasis[MeSHID:D009362]
Plasma[MeSHID:D010949]
Obesity[MeSHID:D009765]
Metabolic Syndrome X[MeSHID:D024821]		 NA approved,investigational potentiator
omega-3-carboxylic acids hydroxyacyl-coenzyme a dehydrogenase, mitochondrial small molecule NA drugbank Hippocampus Proper[MeSHID:D006624]
Hypertriglyceridemia[MeSHID:D015228]
Disease[MeSHID:D004194]
Diet therapy[MeSHID:D004035]
Attention[MeSHID:D001288]
Alcohol consumption[MeSHID:D000428]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Neoplasm Metastasis[MeSHID:D009362]
Plasma[MeSHID:D010949]
Obesity[MeSHID:D009765]
Metabolic Syndrome X[MeSHID:D024821]		 NA approved,investigational potentiator
omega-3-carboxylic acids 3-hydroxyacyl-coa dehydrogenase type-2 small molecule NA drugbank Hippocampus Proper[MeSHID:D006624]
Hypertriglyceridemia[MeSHID:D015228]
Disease[MeSHID:D004194]
Diet therapy[MeSHID:D004035]
Attention[MeSHID:D001288]
Alcohol consumption[MeSHID:D000428]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Neoplasm Metastasis[MeSHID:D009362]
Plasma[MeSHID:D010949]
Obesity[MeSHID:D009765]
Metabolic Syndrome X[MeSHID:D024821]		 NA approved,investigational potentiator
omega-3-carboxylic acids lipoprotein lipase small molecule NA drugbank Hippocampus Proper[MeSHID:D006624]
Hypertriglyceridemia[MeSHID:D015228]
Disease[MeSHID:D004194]
Diet therapy[MeSHID:D004035]
Attention[MeSHID:D001288]
Alcohol consumption[MeSHID:D000428]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Neoplasm Metastasis[MeSHID:D009362]
Plasma[MeSHID:D010949]
Obesity[MeSHID:D009765]
Metabolic Syndrome X[MeSHID:D024821]		 NA approved,investigational stimulator
click here to return to the previous page